Compounds that inhibit Hsp90 protein-protein interactions...

Details Compounds that inhibit Hsp90 protein-protein interactions... Compounds that inhibit Hsp90 protein-protein interactions...

2005-07-22

2008-03-11

Tsang, Cecilia J. (Department: 1654)

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

25 or more amino acid residues in defined sequence

C530S325000, C530S326000, C530S327000, C530S328000, C530S329000, C514S002600

Reexamination Certificate

active

07342093

ABSTRACT:
Disclosed herein are compounds that inhibit Hsp90 interactions with IAP proteins, such as Survivin, XIAP, cIAP1, or cIAP2, and methods for identifying and using such compounds.

REFERENCES:
patent: 6245523 (2001-06-01), Altieri
patent: 6346389 (2002-02-01), Altieri
patent: 6509162 (2003-01-01), Altieri
patent: 6541457 (2003-04-01), Korneluk et al.
patent: 6800737 (2004-10-01), Altieri
patent: 6943150 (2005-09-01), Altieri
patent: 7097966 (2006-08-01), Altieri et al.
patent: 2002/0177212 (2002-11-01), Patterson et al.
patent: 2003/0143232 (2003-07-01), Altieri
patent: 2003/0194704 (2003-10-01), Penn et al.
patent: 2004/0126775 (2004-07-01), Altieri et al.
patent: 2004/0180354 (2004-09-01), Simard et al.
patent: 2005/0143308 (2005-06-01), Altieri
patent: 2006/0068453 (2006-03-01), Altieri
patent: 2006/0069025 (2006-03-01), Altieri
patent: 2007/0065842 (2007-03-01), Altieri et al.
patent: WO 98/22589 (1998-05-01), None
patent: WO 02/057787 (2002-07-01), None
Adida et al., “Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation,” Am. J. Pathol., 152:43-9 (1998).
Altieri, “Molecular cloning of effector cell protease receptor-1, a novel cell surface receptor for the protease factor Xa,” J. Biol. Chem., 269:3139-42 (1994).
Altieri, “Splicing of effector cell protease receptor-1 mRNA is modulated by an unusual retained intron,” Biochem., 33:13848-55 (1994).
Altieri, “Xa receptor EPR-1,” FASEB J. 9:860-5 (1995).
Ambrosini and Altieri, “Molecular dissection of effector cell protease receptor-1 recognition of factor Xa: assignment of critical residues involved in antibody reactivity and ligand binding,” J. Biol. Chem., 271:1243-8 (1996).
Ambrosini et al., “A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma,” Nat. Med., 3:917-921 (1997).
Basso et al., “Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2,” Oncogene, 21:1159-1166 (2002).
Birnhaum et al. , “An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifs,” J. Virol., 68:2521-8 (1994).
Bonny et al., “Cell-permeable peptide inhibitors of JNK: novel blockers of β-cell death,” Diabetes, 50:77-82 (2001).
Chen et al., “Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists,” Proc. Natl. Acad. Sci. USA, 96:4325-4329 (1999).
Clem and Miller, “Control of programmed cell death by the baculovirus genes p35 and iap,” Mol. Cell. Biol., 14:5212-22 (1994).
Clem et al., “Anti-apoptotic genes of baculoviruses,” Death and Differentiation, 3:9-16 (1996).
Deveraux and Reed, “IAP family proteins—suppressors of apoptosis”, Genes Dev., 13:239-252 (1999).
Duchosal et al., “In vivo immunosuppression by targeting a novel protease receptor,” Nature 380:352-6 (1996).
Duckett et al., “A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors,” EMBO J., 15:2685-94 (1996).
Fortugno et al., “Regulation of survivin function by Hsp90,” Proc. Natl. Acad. Sci. USA, 100:13791-796 (2003).
Fortugno et al., “Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function,” J. Cell Sci., 115:575-585 (2002).
Grossman et al., “Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma,” J. Invest. Dermatol., 113:1076-81 (1999).
Grossman et al., “Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line,” Lab. Invest., 79:1121-6 (1999).
Hay et al., “Drosophila homologs of baculovirus inhibitor of apoptosis proteins function to block cell death,” Cell 83:1253-62 (1995).
Hengartner, “Cell death and aging, molecular mechanisms of,” Molecular Biology and Biotechnology, A Comprehensive Desk Reference, 1995.
Hom et al., “Design and synthesis of statine-based cell-permeable peptidomimetic inhibitors of human β-secretase,” J. Med. Chem., 46:1799-1802 (2003).
Kelemen et al., “Selective in vivo inhibition of mitogen-activated protein kinase activation using cell-permeable peptides,” J. Biol. Chem., 277:8741-8748 (2002).
Li et al., “Control of apoptosis and mitotic spindle checkpoint by survivin,” Nature 396:580-584 (1998).
Li et al., “Pleiotropic cell-division defects and apoptosis induced by interference with survivin funtion,” Nat. Cell. Biol., 1:461-6 (1999).
Liston et al., “Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes,” Nature 379:349-53 (1996).
Lundberg and Johansson, “Positively charged DNA-binding proteins cause apparent cell membrane translocation,” Biochem. Biophys. Res. Comm., 291:367-371 (2002).
Morris et al., “A peptide carrier for the delivery of biologically active proteins into mammalian cells,” Nature Biotech., 19:1173-1176 (2001).
O'Connor et al., “Regulation of apoptosis at cell division by p34cdc2phosphorylation of survivin,” Proc. Natl. Acad. Sci. USA, 97:13103-7 (2000).
Plescia et al., “Rational design of shepherdin, a novel anticancer agent,” Cancer Cell, 7:457-468 (2005).
Rothe et al., “The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins,” Cell, 83:1243-52 (1995).
Roy et al., “The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy,” Cell, 80:167-78 (1995).
Stebbins et al., “Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent,” Cell, 89:239-250 (1997).
Zou et al., “An APAF-1•cytochromecmultimeric complex is a functional apoptosome that activates procaspase-9,” J. Biol. Chem., 274:11549-56 (1999).

Affiliated with

Also associated with

Rating

Compounds that inhibit Hsp90 protein-protein interactions... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds that inhibit Hsp90 protein-protein interactions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds that inhibit Hsp90 protein-protein interactions... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3977239